Other treatments

Exosomes for Hair Loss: What the Evidence Really Says

Exosome hair treatments have encouraging early findings, but products and procedures vary. Here is what human studies show, what the FDA warns about, and what to ask before booking.

PDRN Hair editorial · updated Oct 9, 2026 · 9 sources · not medical advice

What to know

  • The FDA states that there are no FDA-approved exosome products.
  • Human studies report encouraging changes, but the evidence remains limited.
  • Small studies without serious adverse events do not establish long-term safety.
  • Clinic prices and treatment methods vary; ask exactly what a quote includes.
  • A comparison with PDRN or PRP is not proof that exosomes work better.

What exosomes are—and what a hair treatment involves

Exosomes are tiny packages that cells release to communicate with other cells. A research review describes them as membrane-enclosed vesicles, meaning small sacs, while a systematic review describes cargo including proteins, fats and genetic messages. That cargo can influence how recipient cells behave. This biological role explains the research interest, but it does not establish that a commercial exosome hair treatment will help your thinning.

The proposed hair effects come partly from preclinical evidence: laboratory and animal work rather than treatment trials in people. A systematic review reports that exosomes may encourage follicles to enter anagen, the active growth phase, and reduce follicular cell death. Those findings are reasons to investigate treatment, not evidence that every product sold under the exosome label produces the same effect.

Exosome therapy for hair loss is not a single standardized procedure. Northwestern Medicine describes topical application with a microneedling roller, which creates small channels in the scalp, and says ultrasound may also be used. A separate prospective human study investigated scalp injections. Ask which method a clinic offers rather than assuming that topical application and injections have interchangeable evidence.

The source of the material also matters when you read a study. The systematic review covers different exosome sources and formulations, while the prospective injection study used material derived from foreskin-derived mesenchymal stromal cells. These are connective-tissue-associated cells. A clinic should identify its product and explain whether its source and application method match the human research it cites.

Sources 2, 3, 4, 7

Regulation and safety: what the FDA says

There are no FDA-approved exosome products, according to the FDA's consumer alert. The agency says exosome products intended to treat diseases or conditions in humans generally require its approval. For you, the distinction is straightforward: a clinic offering treatment is not evidence of FDA approval. The regulatory information cited here concerns the United States; it does not establish authorization elsewhere.

The FDA warns that illegally marketed regenerative medicine products may lack demonstrated safety or effectiveness and may pose significant safety risks. That warning deserves attention even when a provider describes its treatment as natural or minimally invasive. Those descriptions are not substitutes for product-specific evidence, and a reassuring explanation of how cells communicate cannot establish the safety of the material being applied.

Small human studies provide some reassurance, but not a complete safety picture. A systematic review reported no serious adverse events in its included hair studies. Another clinical review described very limited human safety and effectiveness data and noted at least 10 serious adverse events in the broader field of dermatology. Those broader reports are not all hair-treatment events, but they caution against blanket safety claims.

Northwestern Medicine says scalp treatment can cause mild pain and tenderness and, rarely, infection. Before considering it, have a dermatologist confirm the cause of your loss, especially with sudden or patchy loss, scarring, pain, itching, scaling, or loss after illness or a new medication. The FDA asks consumers and healthcare professionals to report adverse events involving exosomes to MedWatch.

Sources 1, 2, 4, 6

Not booking a clinic? The VT Cosmetics PDRN Reedle Shot Brush Hair Serum is $21.88 for 100 ml at the VT Cosmetics global store (checked Oct 2026); it is a cosmetic, not a hair-loss treatment. View at the store · affiliate link

Evidence for hair: encouraging findings, unresolved questions

Human evidence is encouraging but still early. A systematic review included 11 clinical studies involving 298 patients, including two randomized controlled trials alongside retrospective studies, single-arm studies, a case series and case reports. Every included study reported improvement in at least one hair measurement. However, these study designs do not all provide the same confidence that treatment caused the observed change.

The systematic review's abstract reports hair-density increases of 9.5 to 35 hairs/cm² and hair-thickness increases of up to 13.01 µm with mesenchymal stem cell-derived exosomes. These are reported study findings, not a prediction for your scalp. The reviewers caution that studies differed, samples were small and follow-up durations varied, making a single expected result difficult to establish.

A prospective study followed 30 men receiving scalp injections and reported statistically significant hair-density increases at weeks 4 and 12. It also reported no side effects or complications during follow-up. The authors classified it as level IV evidence. This is an early human study, not a randomized comparison, so it cannot establish superiority over another treatment or tell you how long changes persist.

Laboratory and animal findings should stay separate from these human results. A study of extracellular vesicles found favorable changes in follicle cells and a mouse model, but it does not establish equivalent effects in people. Clinical reviews call for larger, well-designed trials, longer follow-up and consistent manufacturing. Our research guide can help you distinguish a biological explanation from a meaningful treatment comparison.

Sources 2, 3, 6, 9

Exosomes vs PDRN and PRP

The evidence cited here does not establish that exosomes work better than PDRN or PRP. It contains no direct comparison that settles that question, and it does not establish PDRN's effectiveness or relative safety. If you are researching PDRN for hair loss, treat a clinic's comparison as a claim requiring evidence, not as an answer supplied by the exosome studies.

PRP differs in how the treatment material is obtained. Northwestern Medicine describes separating your blood in a centrifuge and injecting a growth-factor-containing layer into the scalp. It describes exosome treatment material as prepared and packaged in a laboratory. That practical distinction may help you understand the procedures, but it does not establish comparative effectiveness. Read our PRP guide before discussing the options.

If you already use minoxidil or receive PRP, the cited evidence does not establish how much benefit adding exosomes would provide. Northwestern Medicine says exosome therapy is more effective alongside other hair-loss medications, but that provider statement is not a quantified add-on treatment result. A treatment review identifies topical minoxidil as an FDA-approved option for androgenetic alopecia, or pattern hair loss.

For a PDRN vs exosomes discussion, ask your dermatologist to separate treatment rationale from demonstrated outcomes. What evidence applies to your cause of hair loss? Does it test the proposed product alone or alongside other care? A treatment-options review recommends decisions based on your needs, adherence, budget and extent of hair loss rather than a practitioner's potential financial benefit.

Sources 2, 4, 8

Marketing red flags, cost quotes and questions to ask

Be cautious when marketing presents exosomes for hair as settled science or implies FDA approval. The FDA states that no exosome products are approved, and clinical reviews still call for stronger trials and manufacturing standards. Ask for the exact product, its source, the planned application method and the human study supporting it. A general exosome review is not evidence for every advertised formulation.

Cost quotes vary substantially and should not be treated as interchangeable. Northwestern Medicine lists $600 to $800 per session and says insurance does not cover it. Cooley Hair Center lists $3,000 to $10,000, depending on the clinic, number of treatments and area treated. The cited pricing facts do not specify country or dollar denomination, so confirm both before using these quotes for your budget.

Ask whether a quote covers a session or a treatment course, which procedures are included, and how follow-up is priced. Cooley Hair Center says it determines individual treatment needs and pricing through consultation and that some patients may need more than one session. Our scalp treatment cost guide can help frame the questions; neither published quote establishes what you will pay.

Promises about speed and safety also need context. Cooley Hair Center says many patients notice improvements within 6–8 weeks, while Northwestern Medicine says results may take six months to a year. These are provider statements, not a dependable timeline for you. Descriptions such as safe, natural or no downtime should not replace a discussion of uncertainty, possible complications and whether treatment suits your diagnosed cause of loss.

Sources 1, 2, 4, 5, 6

Common questions

Are exosomes for hair loss FDA approved?

No. The FDA states that there are no FDA-approved exosome products. It also says products intended to treat diseases or conditions in humans generally require approval. A clinic offering exosome hair treatment does not establish that its product is FDA approved or has demonstrated safety and effectiveness.

Do exosomes work for hair loss?

Early human studies report improvements, but reliable effectiveness is not yet established across products and procedures. A systematic review included 11 studies involving 298 patients and found improvement in at least one hair measurement in every study. The reviewers also highlighted small samples, differing methods and varying follow-up, and called for stronger randomized trials.

How much does exosome hair treatment cost?

Northwestern Medicine lists $600 to $800 per session and says insurance does not cover it. Cooley Hair Center lists $3,000 to $10,000 depending on clinic, treatment number and area treated. These are provider quotes, not a universal range. Confirm country, currency and what is included because the cited pricing facts do not specify those geographic and currency details.

Are exosomes better than PRP or PDRN for hair?

That is not established by the evidence cited here. Northwestern Medicine describes PRP as using a layer separated from your own blood and exosome treatment material as laboratory-prepared. Those differences do not prove better results. The cited exosome reviews call for stronger trials and do not settle a direct comparison with PRP or PDRN.

Sources (9)Where every fact on this page comes from

Checked on the dates shown. Clinic and brand statements are their claims. Studies carry their PubMed ID.

  1. fda.gov · Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes · checked Oct 2026
  2. PubMed Central · Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources · PMC12433634 · checked Oct 2026
  3. link.springer.com · Effectiveness of Exosome Treatment in Androgenetic Alopecia: Outcomes of a Prospective Study · checked Oct 2026
  4. nm.org · Gains in Hair Loss Treatments · checked Oct 2026
  5. haircenter.com · Comprehensive Guide: How Much Does Exosome Treatment Cost? · checked Oct 2026
  6. Dermatologic surgery: official publication for American Society for Dermatologic Surgery [et al.], 2025 · Exosomes for Treating Hair Loss: A Review of Clinical Studies. · PMID 39447204 · checked Oct 2026
  7. Journal of bioscience and bioengineering, 2024 · Exosomes for hair growth and regeneration. · PMID 37996318 · checked Oct 2026
  8. Journal of cosmetic dermatology, 2021 · Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. · PMID 34741573 · checked Oct 2026
  9. Stem cell research & therapy, 2024 · Improvement of androgenic alopecia by extracellular vesicles secreted from hyaluronic acid-stimulated induced mesenchymal stem cells. · PMID 39256806 · checked Oct 2026

Information only, not medical advice. Hair loss has many causes; a board-certified dermatologist can confirm yours and discuss treatment. How this site works.

Read next